Eldora L. Ellison, Ph.D., is a director in Sterne Kessler’s Biotechnology & Chemical and Trial & Appellate Practice Groups. Eldora is a co-chair of the firm’s PTAB Trials practice. Over the course of her 29-year career, Eldora has gained extensive experience in inter partes patent matters, building on a strong foundation in patent prosecution. Her experience includes representing clients in over 80 inter partes review and post grant review proceedings, more than 15 patent interferences, and in various patent reexaminations and district court litigations. For example, Eldora was lead counsel on behalf of patent owner ImmunoGen in Phigenix v. ImmunoGen, 845 F.3d 1168 (Fed. Cir. 2017), in which the Federal Circuit — for the first time since the Court’s inception — established the legal standard for demonstrating standing in an appeal from a final agency action. The Court subsequently dismissed Phigenix’s IPR appeal for lack of standing. More recently, Eldora was designated to lead patent strategist for the University of California on its ground-breaker CRISPR technology, and Eldora has led the University’s renewed interference proceedings. Eldora’s practice also includes preparing and prosecuting patent applications; evaluating patent portfolios (e.g., for due diligence analyses, invalidity, non-infringement, or freedom-to-operate); counseling clients on intellectual property strategy, including Hatch-Waxman issues; and resolving inventorship disputes. She represents a variety of types of clients, including large multinational corporations, start-up companies, and not-for-profit organizations.

Eldora’s intellectual property experience has been principally in technical areas such as biotechnology, pharmaceuticals, molecular biology, therapeutic methods, diagnostic assays, analytical instruments, immunology, virology, bacteriology and vaccines. But she is also called upon to represent clients in other technical areas, given her specialized legal expertise.

Eldora has been recognized as a leading practitioner in the life sciences, and she has served as an expert witness on patent matters. After receiving LMG Life Sciences’ “Post Grant Proceedings Attorney of the Year” award in 2017 and 2019, Eldora was inducted into the organization’s prestigious Hall of Fame in 2021. She is recognized with a nationwide Chambers USA ranking in the “Life Sciences: IP/Patent Litigation” category. Managing Intellectual Property nominated her for its “PTAB Litigator of the Year” award, and it has named her an “IP Star” in 2023 for the eleventh year in a row, while also including her in their “Top 250 Women in IP” several times. The Legal 500 recognized Eldora as a “Leading Lawyer” since 2020 and a “Recommended Lawyer” in 2018 and 2017 for U.S. reexamination and post-grant proceedings. In 2018, she also received the Haverford College Alumni Distinguished Achievement Award for outstanding contributions to her field. The National Law Journal recognized her as one of its “Top 50 Litigation Trailblazers.” Law360 named her an “MVP in Life Sciences” in 2015. LMG Life Sciences nominated her for its “Patent Prosecutor of the Year” award as well as “PTAB Litigator of the Year” in 2016, and it has named her a “Life Sciences Star” since 2012. Profiles in Diversity Journal listed her among “Black Leaders Worth Watching” in 2020 and “Women Worth Watching” in 2016. In 2016, IAM Patent 1000 named her as one of the world’s leading patent professionals and “highly recommended” for post-grant procedures and litigation. Eldora has often been quoted in publications such as IPLaw360 and The Washington Post for her analyses of developments in patent law.

Eldora has served as an advisor to associates participating in the PTAB’s Legal Experience and Advancement Program (LEAP), which provides associates with training and development opportunities in PTAB proceedings, including oral argument.

Eldora is a contributing author of Patent Office Litigation, Second Edition, published in 2017. Additionally, she is an editor of Patent Office Litigation, a two-volume set focused on the new contested proceedings under the America Invents Act, published in 2012 by Thomson Reuters Westlaw. This book examines how the proceedings interact with other aspects of patent procurement and enforcement, and it delivers practical analysis and advice.

She lectures and publishes frequently on topics such as the America Invents Act, patent interferences, patent reexaminations and concurrent patent litigation, and patents and licensing. Eldora has also served on the faculty for the District of Columbia Bar’s Continuing Legal Education Program.

Eldora is a member of the firm’s Executive Committee, and she previously chaired the firm’s Professional Development Committee and the Diversity Committee. Eldora also serves as a member of the Diversity and Inclusion Committee for the Intellectual Property Owners Association, and she is a Co-chair of the Association’s Black IP Professionals Resource Group. She also previously served as a Member of the Board of Directors for Turning Point Academy Public Charter School in Maryland.

Eldora earned her J.D. from Georgetown University Law Center and her Ph.D. in biochemistry, molecular and cell biology from Cornell University, where she serves on the Board of Trustees. Eldora holds a B.S. in biology from Haverford College.

  • Chambers & Partners USA, “Band 3 – Life Sciences: IP/Patent Litigation (USA – Nationwide)” (2023)
  • IAM Patent 1000, “National: Highly Recommended – Post-Grant Proceedings; Washington, DC: Patent Litigation (Bronze Band)” (2023 – 2021)
  • Who’s Who Legal, “IP – Patents” (2023)
  • The Legal 500, “Leading Lawyer – Patent Prosecution (including reexamination and post-grant proceedings)” (2023 – 2020)
  • Managing IP, “Top 250 Women in IP” (2023, 2021 – 2016)
  • World Intellectual Property Review, “WIPR Leaders” (2023 – 2018)
  • Super Lawyers, “Super Lawyers – Washington DC” (2023)
  • IAM Strategy 300, “Global Leaders Guide” (2022)
  • LMG Life Sciences, Hall of Fame Inductee (2021)
  • LMG Life Sciences, “Life Sciences Star” (2023 – 2012)
  • IAM Strategy 300, “A Guide to the World’s Leading IP Strategists” (2021)
  • Profiles in Diversity Journal, “Black Leaders Worth Watching” (2020)
  • IAM Patent 1000, “National: Highly Recommended – Post-Grant Proceedings; Washington, DC: Patent Litigation (Silver Band)” (2020 – 2018)
  • Managing IP, “IP Star” (2023 – 2013)
  • Haverford College, Alumni Distinguished Achievement Award (2018)
  • LMG Life Sciences, “Finalist – Post Grant Proceedings Attorney of the Year” (2022, 2020, 2018)
  • The Legal 500, “Highly Recommended Lawyer – Patent Prosecution (including reexamination and post-grant proceedings)” (2018 – 2017)
  • IAM Patent 1000, “Washington, D.C.: Patent Litigation (Silver Band)” (2018 – 2017)
  • LMG Life Sciences, “Post Grant Proceedings Attorney of the Year” (2019, 2017)
  • Profiles in Diversity Journal, “Women Worth Watching” (2016)
  • IAM Patent 1000, “Highly Recommended Lawyer – Post-Grant Procedures and Litigation” (2016)
  • National Law Journal, “Litigation Trailblazer” (2015)
  • Law360, “‘MVP’ in the Life Sciences category” (2015)

  • J.D., Georgetown University Law Center
  • Ph.D., Biochemistry, Molecular, and Cell Biology, Cornell University
  • B.S., Biology, Haverford College

  • District of Columbia
  • Maryland
  • Supreme Court of the United States
  • U.S. Court of Appeals for the Federal Circuit
  • U.S. District Court for the District of Columbia
  • United States Patent & Trademark Office

  • American Bar Association
  • Maryland State Bar Association
  • National Bar Association
  • Women’s Bar Association
  • Cornell Board of Trustees

Speaking Engagement

PTAB Bar Association 2024 Annual Conference

Washington, DC, Ritz Carlton, March 6, 2024

Speaking Engagement

LSPN Chairman’s Opening Address and Closing Remarks

San Francisco, CA, Hyatt Regency San Francisco, October 10, 2023 9:30 AM - 6:50 PM PST

Speaking Engagement

Going Global: How Can You Maximize the Potential of Your International IP Portfolio?

SAN FRANCISCO, CA, October 11, 2023 3:00 PM - 4:00 PM PST

Speaking Engagement

Chairman’s Opening Address and Closing Remarks

Boston, MA, Revere Hotel Boston Common, May 3, 2023 9:00 AM - 5:00 PM PST

Speaking Engagement

2023 Focus on Pharma

Washington, DC, April 14, 2023 8:30 AM - 6:00 PM PST

Speaking Engagement

PTAB Year in Review

Salt Lake City, UT, Grand America Hotel, February 24, 2023 9:40 AM - 10:40 AM PST

Webinar

Successes and Challenges Faced by Leaders in the Black IP Community

Virtual, February 16, 2023 2:00 PM - 3:00 PM PST

Speaking Engagement

Opening Address and Closing Remarks

San Francisco, California, Hyatt Regency, November 1, 2022 8:30 AM - 6:25 PM PST

Speaking Engagement

The Evolution of the Written Description and Enablement Requirements

Los Angeles, CA, JW Marriott Los Angeles L.A. LIVE, September 20, 2022 2:30 PM - 3:30 PM PST

Speaking Engagement

Advocating for Diversity in IP: Practical Ideas for Implementing Change

Boston, MA, Hyatt Regency Boston, June 29, 2022 4:30 PM - 5:30 PM PST

Speaking Engagement

Chairman’s Opening Address and Closing Remarks

Boston, MA, Boston Convention & Exhibition Center, May 11, 2022 9:00 AM - 4:45 PM PST

Speaking Engagement

Fireside Chat: Plausibility in European Patents – Where Has It Come From and Where Is It Going?

Boston, MA, Boston Convention & Exhibition Center, May 12, 2022 9:25 AM - 9:45 AM PST

Webinar

PTAB LEAP: Preparing for Your AIA Argument

Virtual, May 6, 2022 12:00 PM - 1:00 PM PST

Speaking Engagement

How to Ensure a Smooth Sail at the PTAB: Best Practices for Petitioners & Patent Owners

Virtual, November 9, 2021 10:20 AM - 11:20 AM PST

Speaking Engagement

PTAB Bootcamp

Washington, DC, The Ritz-Carlton, Washington, DC, September 22, 2021 1:00 PM - 3:45 PM PST

Speaking Engagement

IP & Ethics: Current Trends & Best Practices

Virtual, June 4, 2021 1:30 PM - 3:00 PM PST

Speaking Engagement

The Next Innovation Revolution: Biotech and Patents

Virtual, March 22, 2021 10:30 AM - 11:00 AM PST

Speaking Engagement

Inspiring Advice from a Lineup of Influential Senior Level Women in Intellectual Property

Virtual, March 9, 2021 4:00 PM - 5:00 PM PST

Webinar

Careers in STEM

Virtual, February 24, 2021 5:00 PM - 6:00 PM PST

Speaking Engagement

LSPN Connect Perspectives: An Interview with Eldora Ellison

Virtual, October 27, 2020 12:00 PM - 1:00 PM PST

Speaking Engagement

IPR Timing Issues in View of Recent Developments

Virtual, September 24, 2020 2:15 PM - 3:15 PM PST

Speaking Engagement

Patent Litigation & Transactions: Impact of a Potential Global Recession

Virtual, September 24, 2020 1:00 PM - 2:00 PM PST

Speaking Engagement

Advanced Patent Trial and Appeal Board (PTAB) Trial Strategies 2020

Virtual, September 9, 2020 9:00 AM - 12:30 PM PST

Speaking Engagement

Life Sciences Patent Network North America – Fall 2019

San Francisco, CA, Hyatt Regency, October 16, 2019

Speaking Engagement

Life Sciences Patent Network North America – Fall 2018

San Francisco, CA, October 16, 2018

Speaking Engagement

USPTO Post-Grant Patent Trials 2018: Change & Recalibration (New York)

New York, NY, September 21, 2018 9:00 AM - 11:59 PM PST

Speaking Engagement

13th Annual Advanced Patent Law Institute

Alexandria, VA, March 1, 2018

Speaking Engagement

2017 IPO Annual Meeting

San Francisco, CA, September 17, 2017 12:00 AM - 11:59 PM PST

Speaking Engagement

MIP Life Sciences Forum

New York, NY, September 13, 2017

Speaking Engagement

Pharma Lessons from the PTAB: Litigation and Prosecution

Webinar, June 8, 2017 2:00 PM - 3:00 PM PST

Speaking Engagement

Life Sciences Patent Network

Boston, MA, June 1, 2017

Speaking Engagement

Managing Intellectual Property PTAB Forum 2016

New York, NY, May 12, 2016 9:20 AM - 10:10 AM PST

AIPLA Mid-Winter Institute

January 27, 2016

4th Annual Pharma IPR India

February 11, 2015

Related Resources

From Eldora L. Ellison, Ph.D.

In the News

February 7, 2024

PTAB Filings Drop Alongside Declining Patent Litigation

Law360

In the News

November 27, 2023

PTAB Denies Review Of Univ. Of Texas System Cancer Patent

Law360

Firm Announcements

November 27, 2023

Sterne Kessler Secures Denial of PGR for Largest Cancer Center in the US

Sterne, Kessler, Goldstein & Fox

Press Release

September 21, 2023

LMG Life Sciences Ranks Sterne Kessler and Seven Directors for Patent Litigation and Prosecution

Sterne, Kessler, Goldstein & Fox

In the News

August 11, 2023

US Director Review Ruling Shows Vidal’s Willingness To Fix Errors

Managing IP

Press Release

August 11, 2023

Six Sterne Kessler Directors Ranked in Who’s Who Legal: IP 2023 Global Guide

Sterne, Kessler, Goldstein & Fox

Press Release

July 6, 2023

Sterne Kessler and 14 Directors Earn Top Rankings in Managing IP’s 2023 “IP Stars” Guide

Sterne, Kessler, Goldstein & Fox

Press Release

July 6, 2023

Six Sterne Kessler Directors Distinguished by World Intellectual Property Review as 2023 WIPR Leaders

Sterne, Kessler, Goldstein & Fox

Press Release

June 8, 2023

Sterne Kessler and Director Ellison Ranked for Patent Prosecution in the 2023 Edition of The Legal 500

Sterne, Kessler, Goldstein & Fox

Press Release

June 1, 2023

Chambers USA Exclusively Awards Sterne Kessler the Band 1 Patent Prosecution Ranking Among D.C. Firms

Sterne, Kessler, Goldstein & Fox

In the News

April 26, 2023

World IP Day Pledges From Women Across the Industry

World IP Review

Press Release

April 24, 2023

Super Lawyers Recognizes 14 Sterne Kessler Attorneys as 2023 “Super Lawyers” and “Rising Stars”

Sterne, Kessler, Goldstein & Fox

Podcast Recording & Transcript

February 15, 2023

From PhD to Partner: Biotechnology and Patent Law w/ Eldora Ellison

In the News

November 21, 2022

PTAB Told Chemical Co.'s Tech Has 'Full Promise' Of CRISPR

Law360

Press Release

September 30, 2022

Sterne Kessler Director Eldora L. Ellison Appointed to Advisory Council for the CAFC

Sterne, Kessler, Goldstein & Fox

Press Release

September 22, 2022

Sterne Kessler and Seven Directors Recognized in LMG Life Sciences Rankings for the 10th Consecutive Year

Sterne, Kessler, Goldstein & Fox

In the News

September 12, 2022

Korean Co. Can't Be First To Invent CRISPR, PTAB Told

Law360

Press Release

September 9, 2022

Sterne Kessler Wins Hatch-Waxman Impact Case of the Year Award at 2022 LMG Life Sciences Americas Awards

Sterne, Kessler, Goldstein & Fox

Firm Announcements

June 24, 2022

Director Eldora L. Ellison, Ph.D. Testifies Before U.S. House of Representatives Committee on the Judiciary

Sterne, Kessler, Goldstein & Fox

Press Release

June 9, 2022

Sterne Kessler Recognized as “Top Tier” Patent Prosecution Firm by The Legal 500

Sterne, Kessler, Goldstein & Fox

In the News

June 2, 2022

New Trustees to Join Cornell Board

Cornell Chronicle

Press Release

June 2, 2022

Four Sterne Kessler Directors Named “WIPR Leaders” By World Intellectual Property Review

Sterne, Kessler, Goldstein & Fox

In the News

April 28, 2022

Patent Tribunal Judges Urge Firms to Send Women, Diverse Lawyers

Bloomberg Law

In the News

April 1, 2022

Skilled in the Art With Scott Graham

Law.com

Reports

March 7, 2022

2021 PTAB Year in Review: Analysis & Trends

Sterne, Kessler, Goldstein & Fox Multiple Authors

Bylined Articles

March 7, 2022

Case Studies and Trends at the PTAB Involving 35 U.S.C. § 112

Sterne, Kessler, Goldstein & Fox Multiple Authors

Bylined Articles

March 7, 2022

Editors' Introduction

Sterne, Kessler, Goldstein & Fox Multiple Authors

Press Release

March 7, 2022

Sterne Kessler Publishes 2021 PTAB Year in Review: Analysis & Trends Report

Sterne, Kessler, Goldstein & Fox Multiple Authors

In the News

March 1, 2022

Minority in IP: Navigating a Lonely Road

Washington Lawyer Multiple Authors

In the News

February 4, 2022

PTAB Judge Grills UC on Evidence It Invented CRISPR First

Law360 Multiple Authors

In the News

February 4, 2022

New CRISPR Patent Hearing Continues High-Stakes Legal Battle

Science Multiple Authors

Press Release

January 17, 2022

Four Sterne Kessler Directors Featured in IAM Strategy 300 Global Leaders 2022 Guide

Sterne, Kessler, Goldstein & Fox Multiple Authors

In the News

December 17, 2021

Moderna Delays Bid for Covid Shot Patent Disputed by NIH

Bloomberg Multiple Authors

Press Release

September 29, 2021

Sterne Kessler and Seven Directors Earn Top-Tier Designations in 2021 LMG Life Sciences Rankings

Sterne, Kessler, Goldstein & Fox Multiple Authors

Press Release

September 23, 2021

Directors Ellison, Rozendaal, and Sterling Win Prominent LMG Life Sciences Americas Awards

Sterne, Kessler, Goldstein & Fox Multiple Authors

In the News

September 23, 2021

USPTO Faces Growing Pressure To Enter Battle Over Drug Pricing

Pink Sheet Multiple Authors

Press Release

August 31, 2021

Directors Bodenstein, Durkin, Ellison, and Sterne Ranked in 2021 IAM Strategy 300

Sterne, Kessler, Goldstein & Fox Multiple Authors

In the News

August 11, 2021

Tell Us More: Advocating for Biotechnology's Biggest Innovators

Haverford Magazine Multiple Authors

Press Release

July 26, 2021

Sterne, Kessler, Goldstein & Fox Earns 13 Market-Leading Awards for Excellence in the First Six Months of 2021

Sterne, Kessler, Goldstein & Fox Multiple Authors

Press Release

July 9, 2021

Managing IP Names Director Eldora L. Ellison, Ph.D. Among the “Top 250 Women in IP” Globally

Sterne, Kessler, Goldstein & Fox Multiple Authors

Press Release

July 1, 2021

Sterne, Kessler, Goldstein & Fox and 16 Directors Recognized for Excellence in 2021 IAM Patent 1000 Rankings

Sterne, Kessler, Goldstein & Fox Multiple Authors

Press Release

June 17, 2021

Sterne Kessler and 13 Directors Earn Top Rankings for IP Litigation and Prosecution in 2021 “IP Stars” Guide

Sterne, Kessler, Goldstein & Fox Multiple Authors

Press Release

June 14, 2021

Sterne Kessler Recognized as a “Top Tier” Patent Prosecution Firm by The Legal 500

Sterne, Kessler, Goldstein & Fox Multiple Authors

Press Release

April 29, 2021

Director Eldora L. Ellison, Ph.D. Ranked Again in WIPR Leaders 2021 Guide

Sterne, Kessler, Goldstein & Fox Multiple Authors

Press Release

April 20, 2021

Sterne Kessler’s IP Hot Topics Podcast Wraps First Quarter Episodes with Howard University President

Sterne, Kessler, Goldstein & Fox Multiple Authors

Firm Announcements

March 17, 2021

Walter Isaacson’s New Book “Code Breaker” about the inventors of CRISPR Technology features Sterne Kessler Director Eldora Ellison

Sterne, Kessler, Goldstein & Fox P.L.L.C. Multiple Authors

In the News

January 18, 2021

Five Ways IP Firms Furthered Diversity and Inclusion Last Year

Managing IP Multiple Authors

Press Release

December 10, 2020

Director Eldora L. Ellison, Ph.D. Named Among 2020 “Black Leaders Worth Watching”

Sterne, Kessler, Goldstein & Fox Multiple Authors

Podcast Recording & Transcript

October 13, 2020

Innovation Conversations: Walter Isaacson, Part 2

Multiple Authors

Press Release

October 8, 2020

Sterne Kessler Client Wins 2020 Nobel Prize in Chemistry for CRISPR-Cas9 Technology

Sterne, Kessler, Goldstein & Fox P.L.L.C. Multiple Authors

In the News

October 8, 2020

Legal Industry News: Law Firm Hires, Recognition & Attorneys Getting Out the Vote

National Law Review Multiple Authors

Press Release

October 6, 2020

Firm and Seven Directors Recognized in 2020 LMG Life Sciences Rankings

Sterne, Kessler, Goldstein & Fox P.L.L.C. Multiple Authors

Press Release

October 6, 2020

Firm Client Sanaria Wins 2020 Patents for Humanities Award from USPTO and an Annual Vaccine Industry Excellence Award

Sterne, Kessler, Goldstein & Fox Multiple Authors

Client Alert

September 24, 2020

IP Hot Topic: Podcast Launched with Guest Walter Isaacson

Multiple Authors

Press Release

September 24, 2020

Sterne, Kessler, Goldstein & Fox Wins Two 2020 LMG Life Sciences Americas Awards

Sterne, Kessler, Goldstein & Fox P.L.L.C. Multiple Authors

Podcast Recording & Transcript

September 23, 2020

Innovation Conversations: Walter Isaacson, Part 1

Multiple Authors

Press Release

September 23, 2020

Sterne, Kessler, Goldstein & Fox Launches IP Hot Topics Podcast with Guest Walter Isaacson

Sterne, Kessler, Goldstein & Fox P.L.L.C. Multiple Authors

Bylined Articles

August 5, 2020

Promoting Diversity in IP Law: How Small Actions Can Lead to Big Changes

World Intellectual Property Review Eldora L. Ellison, Ph.D., Gaby L. Longsworth, Ph.D.

Client Alert

July 7, 2020

IP Hot Topic: Patent Prosecution Tool Kit

Carla Ji-Eun Kim

Reports

July 7, 2020

Patent Prosecution Tool Kit

Sterne, Kessler, Goldstein & Fox Multiple Authors

Bylined Articles

July 7, 2020

1.132 Declarations for Traversing Rejections

Sterne, Kessler, Goldstein & Fox Multiple Authors

In the News

July 1, 2020

Patent Litigation Is on the Rebound, Led by WD-Texas Filings

Law.com Multiple Authors

Press Release

June 16, 2020

Sterne, Kessler, Goldstein & Fox and 15 Directors Earn Top Rankings in IAM Patent 1000

Sterne, Kessler, Goldstein & Fox P.L.L.C. Multiple Authors

In the News

June 15, 2020

Black IP lawyers reveal struggles with systemic racism

Managing IP Multiple Authors

In the News

June 12, 2020

'Take That On': Black Patent Attorneys Say It's Time They Are Recognized

Law.com Multiple Authors

Press Release

June 11, 2020

Durkin, Ellison, and Talley Again Named Among “Top 250 Women in IP” by Managing IP

Sterne, Kessler, Goldstein & Fox P.L.L.C. Multiple Authors

Press Release

June 10, 2020

Sterne, Kessler, Goldstein & Fox Ranked as a Top Tier Patent Prosecution Firm by The Legal 500

Sterne, Kessler, Goldstein & Fox P.L.L.C. Multiple Authors

In the News

May 19, 2020

Broad, UC Each Tell PTAB It Invented CRISPR First

Law360 Multiple Authors

Press Release

May 5, 2020

Sterne Kessler Ranked and 13 Directors Named “IP Stars” by Managing Intellectual Property

Sterne, Kessler, Goldstein & Fox P.L.L.C. Multiple Authors

Bylined Articles

April 23, 2020

Patenting Personalized Nutrition Is Challenging But Feasible

Law360 Eldora L. Ellison, Ph.D., Paul A. Calvo, Ph.D.

Press Release

March 26, 2020

Sterne Kessler Named "PTAB Firm of the Year" by Managing IP for Third Time

Sterne, Kessler, Goldstein & Fox P.L.L.C. Eldora L. Ellison, Ph.D., Paul A. Calvo, Ph.D.

Press Release

March 17, 2020

Sterne Kessler Publishes Two Reports -- PTAB Year in Review and Federal Circuit Appeals from the PTAB

Sterne, Kessler, Goldstein & Fox P.L.L.C. Eldora L. Ellison, Ph.D., Paul A. Calvo, Ph.D.

Client Alert

March 4, 2020

IP Hot Topic: 2019 PTAB Year in Review: Analysis & Trends

Multiple Authors

Publication

February 28, 2020

Introduction -- 2019 PTAB Year in Review: Analysis & Trends

Sterne, Kessler, Goldstein & Fox P.L.L.C. Multiple Authors

Press Release

February 28, 2020

Sterne Kessler Publishes 2019 PTAB Year in Review Report

Sterne, Kessler, Goldstein & Fox P.L.L.C. Multiple Authors

Publication

February 27, 2020

Data & Trends -- 2019 PTAB Year in Review: Analysis & Trends

Sterne, Kessler, Goldstein & Fox P.L.L.C. Multiple Authors

In the News

February 3, 2020

Amgen Asks Fed. Circ. To Review Merck's $2.5B Patent Loss

Law360 Multiple Authors

Press Release

January 31, 2020

Four Sterne Kessler Directors Named "WIPR Leaders"

Sterne, Kessler, Goldstein & Fox P.L.L.C. Multiple Authors

In the News

December 31, 2019

University of California's Foundational CRISPR-Cas9 Patent Portfolio Reaches 20 Total U.S. Patents

University of California, Berkeley Multiple Authors

In the News

October 22, 2019

Influential Women in IP: is it ever OK to cry at work?

World Intellectual Property Review Multiple Authors

In the News

October 1, 2019

UC now holds largest CRISPR-Cas9 patent portfolio

University of California, Berkeley Multiple Authors

In the News

September 24, 2019

University of California awarded 15th U.S. CRISPR-Cas9 patent

University of California, Berkeley Multiple Authors

Press Release

September 23, 2019

Director Eldora L. Ellison, Ph.D. Receives Top Honor at 2019 LMG Life Sciences Awards

Sterne, Kessler, Goldstein & Fox P.L.L.C Multiple Authors

In the News

September 17, 2019

CRISPR portfolio now at 14 and counting

University of California, Berkeley Multiple Authors

In the News

September 10, 2019

University of California gains additional U.S. CRISPR-Cas9 patent related to single-guide RNA

PR Newswire Multiple Authors

In the News

September 8, 2019

UC awarded 12th patent for CRISPR-Cas9 gene-editing technology

The Daily Californian Multiple Authors

In the News

September 3, 2019

Twelfth CRISPR patent awarded to UC team

University of California, Berkeley Multiple Authors

In the News

August 23, 2019

Eleventh U.S. CRISPR-Cas9 Patent Awarded to University of California, U. Vienna, Charpentier

Genetic Engineering & Biotechnology News Multiple Authors

In the News

August 20, 2019

University of California awarded new U.S. CRISPR-Cas9 patent

University of California, Berkeley Multiple Authors

In the News

August 8, 2019

Allergan Fights to Keep Botox-Making Process Secret From Rival

Bloomberg Multiple Authors

In the News

August 6, 2019

The Female Inventor Problem And How Lawyers Are Helping

Law360 Multiple Authors

In the News

July 23, 2019

Newly granted CRISPR patents boost UC’s U.S. portfolio to 10

University of California, Berkeley Multiple Authors

In the News

July 17, 2019

CRISPR-Cas 9 patent granted to University of California

Biopharmapress Multiple Authors

In the News

July 16, 2019

Eighth CRISPR patent issued by U.S.; seven more soon to come

University of California, Berkeley Multiple Authors

In the News

July 2, 2019

Seventh CRISPR Patent Awarded to Doudna/Charpentier Team

University of California, Berkeley Multiple Authors

In the News

June 28, 2019

Interference Declared over CRISPR-Cas9 for Eukaryotic Cells, Reigniting Patent War

Genetic Engineering & Biotechnology News Multiple Authors

In the News

June 28, 2019

New Battle in CRISPR Patent War Adds To The Uncertainty Surrounding The Technology

Intellectual Asset Management Multiple Authors

In the News

June 27, 2019

USPTO Revives Fight Over CRISPR Patents

Life Sciences Intellectual Property Review Multiple Authors

In the News

June 27, 2019

Reopening Conflict Between UC and Broad Institute, Patent Office Takes New Look at CRISPR History

Los Angeles Times Multiple Authors

In the News

June 27, 2019

Dispute Over Patent Rights to CRISPR-Cas9 Renewed By Patent Office

Drug Target Review Multiple Authors

In the News

June 27, 2019

PTAB launches CRISPR patent interference

Intellectual Property Magazine Multiple Authors

In the News

June 26, 2019

USPTO Reverses Decision Regarding Interfering CRISPR Patents

Pharmaceutical Technology Multiple Authors

In the News

June 26, 2019

Surprise Patent Ruling Revives High-Stakes Dispute Over the Genome Editor CRISPR

Science Magazine Multiple Authors

In the News

June 26, 2019

Patent Battle Rekindled as Interference Declared over CRISPR-Cas9 for Eukaryotic Cells

Clinical OMICs Multiple Authors

In the News

June 25, 2019

Patent Office Renews Dispute Over Patent Rights to CRISPR-Cas9

University of California, Berkeley Multiple Authors

In the News

June 25, 2019

CRISPR Patent Fight Between UC Berkeley, Broad Flares Up as USPTO Initiates New Interference

GenomeWeb LLC Multiple Authors

In the News

June 25, 2019

USPTO Launches New Round In CRISPR Patent War

Law360 Multiple Authors

In the News

June 25, 2019

U.S. Patent Agency to Review Harvard, MIT's Claim to CRISPR Technology

WSAU Multiple Authors

In the News

June 25, 2019

Broad, Berkeley Return to Argue CRISPR Invention at Patent Office

Xconomy Multiple Authors

In the News

June 25, 2019

Gene-Editing Battle Heats Up as U.S. Probes Who Invented First

Bloomberg Law Multiple Authors

In the News

June 24, 2019

U.S. Patent Agency to Review Harvard, MIT's Claim to CRISPR Technology

Reuters Multiple Authors

In the News

June 17, 2019

State-Held Patents Fair Game At PTAB After Fed. Circ. Ruling

Law360 Multiple Authors

Press Release

June 12, 2019

Sterne Kessler Prominent Again in Intellectual Asset Management Magazine’s "IAM Patent 1000"

Sterne, Kessler, Goldstein & Fox P.L.L.C Multiple Authors

In the News

June 10, 2019

High Court Leaves Gov't With Few Patent Challenge Options

Law360 Multiple Authors

In the News

June 4, 2019

University of California Awarded Additional U.S. Patent for Regulating Gene Editing and Expression

University of California Office of the President Multiple Authors

In the News

May 29, 2019

University Of California Gets 5th CRISPR Patent

Law360 Multiple Authors

In the News

May 28, 2019

USPTO Issues 5th U.S. CRISPR-Cas9-Related Patent to University of California

University of California Office of the President Multiple Authors

Press Release

May 23, 2019

MIP Distinguishes Three Sterne Kessler Directors Among Top 250 Women in IP

Sterne, Kessler, Goldstein & Fox PLLC Multiple Authors

Press Release

May 20, 2019

Sterne Kessler Tops Managing Intellectual Property’s IP Firm Rankings – Eleven Directors Named "IP Stars"

Sterne, Kessler, Goldstein & Fox P.L.L.C. Multiple Authors

In the News

May 6, 2019

Alumna Spotlight: Eldora L. Ellison

Cornell University Graduate School Multiple Authors

In the News

May 1, 2019

UC Berkeley Receives its 4th CRISPR Patent, Expects 3 More After

The Daily Californian Multiple Authors

In the News

April 29, 2019

UC Receives Fourth CRISPR Patent; Three More on the Way

University of California, Berkeley Multiple Authors

In the News

April 29, 2019

University of California, U. Vienna, Charpentier Awarded Fourth U.S. CRISPR-Cas9 Patent

Genetic Engineering & Biotechnology News Multiple Authors

Press Release

February 20, 2019

Sterne Kessler Directors Recognized Among the World’s Leading IP Practitioners

World Intellectual Property Review Multiple Authors

In the News

February 11, 2019

UC Berkeley Team to Be Awarded CRISPR Patent

The Scientist Multiple Authors

In the News

February 8, 2019

U.S. Patent Office Indicates it will Issue Third CRISPR Patent to UC

University of California, Berkeley Multiple Authors

In the News

February 8, 2019

University of California to be granted pioneering CRISPR patent

Reuters Multiple Authors

In the News

February 8, 2019

Fight Over Who Invented CRISPR Isn’t Done With Berkeley Patent

Bloomberg Law Multiple Authors

Client Alert

October 11, 2018

USPTO Changes Claim Construction Standard in Post-Grant Proceedings

David H. Holman, Ph.D., Eldora L. Ellison, Ph.D.

In the News

October 11, 2018

AIA Claim Construction Change To Spur Revamped Strategies

Law360 David H. Holman, Ph.D., Eldora L. Ellison, Ph.D.

Press Release

September 25, 2018

Sterne Kessler Recognized By LMG Life Sciences Among The Top IP Firms and Attorneys

Sterne, Kessler, Goldstein & Fox David H. Holman, Ph.D., Eldora L. Ellison, Ph.D.

Press Release

September 13, 2018

Sterne Kessler Director Eric Steffe Receives Top Honor And Firm Recognized At 2018 LMG Life Sciences Awards

Sterne, Kessler, Goldstein & Fox David H. Holman, Ph.D., Eldora L. Ellison, Ph.D.

In the News

August 29, 2018

Fed. Circ. Impeding Biopharma Innovation, Justices Told

Law360 David H. Holman, Ph.D., Eldora L. Ellison, Ph.D.

In the News

August 8, 2018

PTAB Rightly Axed Alcon Eye Drop Patent, Fed. Circ. Says

Law360 David H. Holman, Ph.D., Eldora L. Ellison, Ph.D.

Firm Announcements

August 8, 2018

Sterne Kessler Achieves Affirmance of PTAB Decision at Fed Circuit for Akorn

David H. Holman, Ph.D., Eldora L. Ellison, Ph.D.

Press Release

June 7, 2018

Sterne Kessler Named to "IAM Patent 1000" by Intellectual Asset Management Magazine

David H. Holman, Ph.D., Eldora L. Ellison, Ph.D.

In the News

May 28, 2018

What Does Gender Parity In The Legal Industry Look Like?

Law360 David H. Holman, Ph.D., Eldora L. Ellison, Ph.D.

Press Release

May 18, 2018

Three Sterne, Kessler, Goldstein & Fox Directors Named Among Top 250 Women in IP

David H. Holman, Ph.D., Eldora L. Ellison, Ph.D.

Press Release

May 18, 2018

Managing Intellectual Property Recognizes Sterne Kessler A Top Firm in IP with Eight Directors Named "IP Stars"

David H. Holman, Ph.D., Eldora L. Ellison, Ph.D.

Press Release

March 16, 2018

Sterne Kessler Director and Firm Earn Recognition at 2018 Managing Intellectual Property Awards

David H. Holman, Ph.D., Eldora L. Ellison, Ph.D.

Press Release

February 20, 2018

Sterne Kessler Directors Recognized Among the World’s Leading IP Practitioners

World Intellectual Property Review David H. Holman, Ph.D., Eldora L. Ellison, Ph.D.

In the News

February 8, 2018

Biologic Fights Drive PTAB Drug Challenges To Record High

Law360 David H. Holman, Ph.D., Eldora L. Ellison, Ph.D.

In the News

January 31, 2018

Patent Owners Should Think Hard Before Giving Up At PTAB

Law360 David H. Holman, Ph.D., Eldora L. Ellison, Ph.D.

Press Release

December 13, 2017

Sterne Kessler Ranked Among Top U.S. Firms and Attorneys by LMG Life Sciences

David H. Holman, Ph.D., Eldora L. Ellison, Ph.D.

Bylined Articles

October 20, 2017

How District Courts Treat Patent Eligibility In Life Sciences

Law360 Eldora L. Ellison, Ph.D., Jaume M. Canaves, Ph.D.

Bylined Articles

September 26, 2017

A Survey Of Patent Owner Estoppel At USPTO

Law360 Eldora L. Ellison, Ph.D.

Presentations

September 15, 2017

Focus on Pharma Conference 2017 PowerPoint Presentations

Eldora L. Ellison, Ph.D.

In the News

September 14, 2017

PTAB's Petition Limits Are Good News For Patent Owners

Law360 Eldora L. Ellison, Ph.D.

In the News

September 12, 2017

Things We've Learned As The PTAB Turns 5

Law360 Eldora L. Ellison, Ph.D.

Bylined Articles

September 11, 2017

PTAB At 5: Part 1 — Surprises And Lessons Learned

Law360 Multiple Authors

In the News

August 2, 2017

Patent Pool Seeks to Ease Gene-Editing Tech Licensing

Bloomberg BNA - Patent, Trademark & Copyright Journal Multiple Authors

In the News

July 24, 2017

More PTAB Fights Between Big Pharma Could Be Looming

Law360 Multiple Authors

Books and Chapters

June 28, 2017

Patent Prosecution Tool Kit

Multiple Authors

In the News

June 13, 2017

AIA Constitutionality Case Could Create Patent Law Chaos

Law360 Multiple Authors

Bylined Articles

June 2, 2017

The Evolving Scope of Estoppels Arising from Inter Partes Reviews

Bloomberg BNA Eldora L. Ellison, Ph.D., R. Wilson “Trey” Powers III, Ph.D.

Press Release

May 31, 2017

Sterne Kessler Ranked Among Best IP Firms In The U.S. By The Legal 500

Eldora L. Ellison, Ph.D., R. Wilson “Trey” Powers III, Ph.D.

Press Release

May 25, 2017

Sterne Kessler Ranked Among Top Firms and Firm's Directors Recognized as "IP Stars" by Managing Intellectual Property

Eldora L. Ellison, Ph.D., R. Wilson “Trey” Powers III, Ph.D.

Press Release

May 25, 2017

Four Sterne, Kessler, Goldstein & Fox Directors Named Among Top 250 Women in IP

Eldora L. Ellison, Ph.D., R. Wilson “Trey” Powers III, Ph.D.

Bylined Articles

April 3, 2017

Top 5 PTAB Tips for Big Pharma

New Jersey Law Journal Eldora L. Ellison, Ph.D., R. Wilson “Trey” Powers III, Ph.D.

In the News

April 3, 2017

Hedge Fund Drug Patent Challenges In Doubt After Bass' Test

Law360 Eldora L. Ellison, Ph.D., R. Wilson “Trey” Powers III, Ph.D.

Press Release

March 7, 2017

Sterne Kessler Directors Recognized Among the World’s Leading IP Practitioners

Eldora L. Ellison, Ph.D., R. Wilson “Trey” Powers III, Ph.D.

Books and Chapters

February 17, 2017

Patent Office Litigation - Second Edition 2017

Thomson Reuters Westlaw Multiple Authors

In the News

January 27, 2017

Patent Board's Immunity Finding A Win For State Universities

Law360 Multiple Authors

Client Alert

January 11, 2017

Federal Circuit Dismisses IPR Appeal for Lack of Standing

Multiple Authors

In the News

January 10, 2017

Federal Circuit Dismisses Phigenix Patent Appeal In ImmunoGen Case

Life Sciences Intellectual Property Review Multiple Authors

In the News

November 23, 2016

PTAB Invalidates Claims In Durezol Eye Drops Patent

Law360 Multiple Authors

Bylined Articles

September 14, 2016

The Post-AIA Battleground For Patent Challenges

Law360 Multiple Authors

Press Release

September 14, 2016

Sterne Kessler Named IPR Firm of the Year by LMG Life Sciences

LMG Life Sciences Multiple Authors

News

August 2, 2016

Troll' Asks Fed. Circ. To Save Scanner IP In Xerox Row

Law360 Multiple Authors

Press Release

June 17, 2016

Legal 500 Ranks Sterne Kessler Among Best IP Firms in the United States

Multiple Authors

In the News

February 16, 2016

PTAB's Skyrocketing Petition Rate Starts To Stabilize

Law360 Multiple Authors

Bylined Articles

December 28, 2015

Inter Partes Reviews: The Effect of Estoppel

World Intellectual Property Review Eldora L. Ellison, Ph.D., David H. Holman, Ph.D.

Press Release

December 22, 2015

Law360 Names Sterne Kessler's Dr. Eldora Ellison "Life Sciences' MVP

Eldora L. Ellison, Ph.D., David H. Holman, Ph.D.

In the News

December 14, 2015

New Patent Battleground: Inter Partes Reviews Besiege Innovators

IN VIVO Eldora L. Ellison, Ph.D., David H. Holman, Ph.D.

Bylined Articles

December 8, 2015

Diagnostic Method Patents — Not All Hope is Lost

Westlaw Journal: Intellectual Property Eldora L. Ellison, Ph.D.

Press Release

November 9, 2015

Sterne Kessler Director Named Law360 MVP in "Life Sciences"

Eldora L. Ellison, Ph.D.

In the News

October 29, 2015

ImmunoGen Cancer Patent Still Valid After Phigenix's Dispute

Bloomberg BNA Eldora L. Ellison, Ph.D.

In the News

October 28, 2015

PTAB Upholds ImmunoGen’s Breast Cancer Drug Patent

Law360 Eldora L. Ellison, Ph.D.

In the News

September 29, 2015

PTAB Decision Not To Sanction Bass Shifts Focus To Capitol

Law360 Eldora L. Ellison, Ph.D.

Press Release

September 16, 2015

Sterne, Kessler, Goldstein & Fox Named 2015 LMG Life Sciences' Patent Prosecution Firm of the Year

Eldora L. Ellison, Ph.D.

In the News

September 10, 2015

Law360's "AIA Survival Guide"

Law360 Eldora L. Ellison, Ph.D.

Client Alert

August 25, 2015

Post-Grant Proceedings: The Top Seven Things You Should Know About the Proposed Rule Changes

R. Wilson “Trey” Powers III, Ph.D., Eldora L. Ellison, Ph.D.

Bylined Articles

August 21, 2015

The 1st IPR Institution Decisions For Biosimilars

Law360 Eldora L. Ellison, Ph.D., Paul A. Calvo, Ph.D.

Press Release

July 1, 2015

Sterne Kessler Ranked Among Top Firms and Directors Recognized as "IP Stars" by Managing Intellectual Property

Eldora L. Ellison, Ph.D., Paul A. Calvo, Ph.D.

Press Release

May 22, 2015

Sterne Kessler Directors Named to Intellectual Asset Management's 2015 "IAM 1000"

Eldora L. Ellison, Ph.D., Paul A. Calvo, Ph.D.

Bylined Articles

March 19, 2015

Post-Grant Proceedings Are Important For Biosimilars

Law360 Paul A. Calvo, Ph.D., Eldora L. Ellison, Ph.D.

Bylined Articles

February 28, 2015

The Curious Case of RPIs & NPEs in IPRs

Bloomberg BNA Patent Trademark & Copyright Journal Eldora L. Ellison, Ph.D.

Press Release

February 13, 2015

Sterne Kessler Named Finalist for Managing IP's 2015 North America IP Awards

Eldora L. Ellison, Ph.D.

In the News

February 10, 2015

Docket Navigator Year in Review 2014

Docket Navigator Eldora L. Ellison, Ph.D.

In the News

January 27, 2015

USA Expert Insight Into Biotechnology

Lawyer Monthly Eldora L. Ellison, Ph.D.

In the News

August 27, 2014

Legal Experts Assess Potential Impact of GeneDx's IPR Challenge of Myriad Patents

GenomeWeb’s Pharmacogenomics Reporter Eldora L. Ellison, Ph.D.

In the News

August 20, 2014

Defense to Myriad Patent Infringement Claim Now Moved to Patent Trial and Appeal Board

Bloomberg BNA Patent, Trademark & Copyright Law Daily Bulletin Eldora L. Ellison, Ph.D.

In the News

August 18, 2014

Google, Apple Get Mapping Patent Nixed in AIA Review

Law360 Eldora L. Ellison, Ph.D.

In the News

June 13, 2014

Female Powerbrokers Q&A: Sterne Kessler's Eldora Ellison

Law360 Eldora L. Ellison, Ph.D.

Press Release

June 5, 2014

Ten Sterne Kessler Directors Named IP Stars By Managing Intellectual Property Magazine

Eldora L. Ellison, Ph.D.

In the News

April 9, 2014

Life Sciences Q&A: Eldora L. Ellison, Ph.D

Lawyer Monthly Eldora L. Ellison, Ph.D.